Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: Findings from a preliminary waitlist controlled open trial

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 10, 2006, Pages 1171-1178

  Storch, Eric A ^a   Murphy, Tanya K ^a   Geffken, Gary R ^a   Mann, Giselle ^a   Adkins, Jennifer ^b   J Merlo, Lisa ^b   Duke, Danny ^a   Munson, Melissa ^a   Swaine, Zoe ^a   Goodman, Wayne K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Box 100234 ^*

Author keywords

Cognitive behavioral therapy; Obsessive compulsive disorder; Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ANXIETY; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHOOL CHILD; SELF REPORT; SYMPTOM; UNIVERSITY HOSPITAL;

ADOLESCENT; AUTOANTIBODIES; BRAIN; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; CHILD; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; QUESTIONNAIRES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SYNDROME;

EID: 33749053229     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000231973.43966.a0     Document Type: Article

References (43)

1. Abramowitz JS, Foa EB, Franklin ME (2003), Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions. J Consult Clin Psychol 71:394-398
2. Barrett P, Healy-Farrell L, March JS (2004), Cognitive behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry 43:46-62
3. Barrett P, Farrell L, Dadds M, Boulter N (2005), Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: long-term follow-up and predictors of outcome. J Am Acad Child Adolesc Psychiatry 44:1005-1014
4. Carlson GA, Cantwell DP (1979), A survey of depressive symptoms in a child and adolescent psychiatric population: interview data. J Am Acad Child Psychiatry 18:587-599
5. Cohen J ( 1988), Statistical Power Analysis for the Behavioral Sciences , 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates
6. Craighead WE, Smucker MR, Craighead LW, Wilcoxon L (1998), Factor analysis of the children's depression inventory in a community sample. Psychol Assess 10:156-165
7. de Hann E, Hoogduin KAL, Buitelaar JK, Keijsers GP (1998), Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 37:1022-1029
8. Franklin ME, Kozak MJ, Cashman LA, Coles ME, Rheingold AA, Foa EB (1998), Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. J Am Acad Child Adolesc Psychiatry 37:412-419
9. Garvey MA, Perlmutter SJ, Allen AJ et al. (1999), A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45:1564-1571
10. Geller DA, Biederman J, Stewart SE et al. (2003), Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 160:1919-1928
11. Guy W (1976), Assessment Manual for Psychopharmacology, Revised (DHEW Publication ABM 76-366). Washington, DC: U.S. Government Printing Office
12. Kendall PC, Flannery-Schroeder E, Panichelli-Mindel SM, Southam-Gerow M, Henin M, Warman M (1997), Therapy for youths with anxiety disorders: a second randomized clinical trial. J Consult Clin Psychol 65:366-380
13. Kovacs M (1992), The Children's Depression Inventory. Manual. Toronto: Multi-Health Systems
14. Kurlan R (2004), The PANDAS hypothesis: losing its bite? Mov Disord 19:371-374
15. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM (1982), Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 39:879-883
16. Lewin AB, Storch EA, Merlo LJ, Murphy TK, Geffken GR (2005), Intensive cognitive behavioral therapy for pediatric obsessive compulsive disorder: a treatment protocol for mental health providers. Psychol Serv 2:91-104
17. March JS (1997), Multidimensional Anxiety Scale for Children: Technical Manual. North Tonawanda, NY: Multi-Health Systems
18. March JS (2004), Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): implications for clinical practice. Arch Pediatr Adolesc Med 158:927-929
19. March JS, Biederman J, Wolkow R et al. (1998), Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 280:1752-1756
20. March JS, Parker JD, Sullivan K, Stallings P, Conners CK (1997), The multidimensional anxiety scale for children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 36: 554-565
21. March JS, Sullivan K, Parker JD (1999), Test-retest reliability of the multidimensional anxiety scale for children. J Anxiety Dis 13:349-358
22. Murphy ML, Pichichero ME (2002), Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection. Arch Pediatr Adolesc Med 156:356-361
23. Murphy TK, Sajid M, Soto O et al. (2004), Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry 55:61-68
24. Murphy TK, Storch EA, Strawser M (2006). SSRI-induced behavioral activation in the PANDAS subtype. Prim Psychiatry 13:87-89
25. National Institute of Mental Health (1985), Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:839-843
26. Paykel ES, Scott J, Cornwall PL et al. (2005), Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychol Med 35:59-68
27. Pediatric OCD Treatment Study (POTS) Team (2004), Cognitive-behavioral therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969-1976
28. Perlmutter SJ, Leitman SF, Garvey MA et al. (1999), Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354:1157-1158
29. Pliszka SR, Browne RG, Olvera RL, Wynne SK (2000), A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 39:619-626
30. Riddle MA, Scahill L, King RA et al. (1992), Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 31:1062-1069
31. Scahill L, Riddle MA, McSwiggin-Hardin M et al. (1997), Children's Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852
32. Shytle RD, Silver AA, Sheehan KH et al. (2003), The Tourette's Disorder Scale (TODS): development, reliability and validity. Assessment 10:273-287
33. Silverman WK, Albano AM (1996), The Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions. San Antonio, TX: The Psychological Corporation
34. Silverman WK, Saavedra LM, Pina AA (2001), Test-retest reliability of anxiety symptoms and diagnoses with Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions. J Am Acad Child Adolesc Psychiatry 40:937-944
35. Snider LA, Lougee L, Slattery M, Grant P, Swedo SE (2005), Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 57:788-792
36. Snider LA, Swedo S (2004), PANDAS: current status and directions for research. Mol Psychiatry 9:900-907
37. Storch EA, Murphy TK, Geffken GR et al. (2004a), Psychometric evaluation of the children's Yale-Brown obsessive compulsive scale. Psychiatry Res 129:91-98
38. Storch EA, Murphy TK, Geffken GR et al. (2004b), Further psychometric properties of the Tourette's Disorder Scale-Parent Rated Version. Child Psychiatry Hum Dev 35:107-120
39. Storch EA, Gerdes A, Adkins J, Geffken GR, Star J, Murphy TK (2004c), Behavioral treatment of child with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection. J Am Acad Child Adolesc Psychiatry 43:510-511
40. Storch EA, Murphy TK, Geffken GR, Duke D, Goodman WK (2005), Cognitive-behavioral treatment for pediatric obsessive-compulsive disorder: comparison of intensive versus weekly treatment. Paper presented at the Annual Meeting of the Anxiety Disorders Association of America, Miami, March 23-26
41. Swedo SE, Leonard HL, Garvey M et al. (1998), Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155:264-271
42. Tolin DF, Maltby N, Diefenbach GJ, Hannan SE, Worhunsky P (2004), Cognitive-behavioral therapy formedication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry 65:922-931
43. Wood JJ, Piacentini JC, Bergman RL, McCracken J, Barrios V (2002), Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions. J Clin Child Adolesc Psychol 31:335-342